PARENTERAL METHOTREXATE IN REFACTORY CROHN'S DISEASE: EXPERIENCE IN A DISTRICT GENERAL HOSPITAL
- USE OF METHOTREXATE FOR INDUCTION OF REMISSION IN CROHN'S DISEASE. // Archives of Disease in Childhood;Apr2003 Supplement, Vol. 88, pA15
Presents an abstract of the study 'Use of Methotrexate for Induction of Remission in Crohn's Disease: A Retrospective Cohort Study,' by L. Pieterse, P. Rogers, D. Hoole, P.M. Gillett and D.C. Wilson, presented at the 7th Spring Meeting of the Royal College of Paediatrics and Child Health.
- Methotrexate for Maintaining Remission of Crohn's Disease. Kirchner, Jeffrey T. // American Family Physician;12/1/2000, Vol. 62 Issue 11, p2506
Presents an abstract of the study `A Comparison of Methotrexate With Placebo for the Maintenance of Remission in Crohn's Disease,' by B.G. Feagan et al., from the June 1, 2000 issue of the `New England Journal of Medicine.'
- Pharmacokinetic profiles for oral and subcutaneous methotrexate in patients with Crohn's disease. Wilson, A. // Inflammatory Bowel Disease Monitor;2013, Vol. 13 Issue 3, p121
A review of the article "Pharmacokinetic profiles for oral and subcutaneous methotrexate in patients with Crohn's disease," by A. Wilson and colleagues, which appeared in the periodical "Alimentary Pharmacology & Therapeutics" in the 2013 issue is presented.
- Methotrexate. // Reactions Weekly;12/1/2007, Issue 1180, p28
The article describes the case of a 36-year-old obese woman who developed pneumonitis during treatment with methotrexate for Crohn's disease. The patient has been receiving prednisolone, weekly IM methotrexate 25mg and folic acid. She experienced progressive oral and retrosternal pain, dry cough...
- Methotrexate effective for maintenance of remission in Crohn's disease. McAvoy, Brian R. // New Zealand Doctor;3/10/2010, p28
The article presents a study that examined the effectiveness of methotrexate for maintenance of remission in Crohn's disease.
- Crohn's disease: Methotrexate can reduce prednisone requirements. // Modern Medicine;May95, Vol. 63 Issue 5, p55
Presents an abstract of the article `Methotrexate for the Treatment of Crohn's Disease,' by B.G. Feagan, J. Rochon, et al published in the periodical `The New England Journal of Medicine,' dated February 2, 1995.
- Clinical experience of methotrexate in Crohn's disease: response, safety and monitoring of treatment. Parker, Richard; Dixit, Anyinda; Fraser, Aileen; Creed, Tom J.; Probert, Chris S. // Postgraduate Medical Journal;Apr2010, Vol. 86 Issue 1014, p208
Background Methotrexate is an immunosuppressant used in the treatment of patients with Crohn's disease who are intolerant or refractory to azathioprine. Aim To present clinical experience in terms of response, side effects and reason for cessation of methotrexate treatment as well as adherence...
- Dosing 6-Thioguanine in Inflammatory Bowel Disease: Expert-Based Guidelines for Daily Practice. Seinen, Margien L.; Van Asseldonk, Dirk P.; Mulder, Chris J. J.; de Boer, Nanne K. H. // Journal of Gastrointestinal & Liver Diseases;
Conventional thiopurines are considered to be effective and safe in the treatment of inflammatory bowel disease (IBD) patients; unfortunately more than 50% of patients discontinue thiopurine therapy, mainly due to the development of intractable adverse events. In recent years, the use of...
- Immunomodulation does not alter histology in resected Crohnâ€™s disease. Frizelle, F. A.; Ing, A.; Gearry, R. B.; Whitehead, M.; Faragher, I. G.; Dobbs, B. // Techniques in Coloproctology;Dec2009, Vol. 13 Issue 4, p295
The use of immunomodulators (Azathioprine, 6-Mercaptopurine and Methotrexate) and biological agents (Infliximab and adalimumab) for the treatment of Crohnâ€™s disease (CD) has increased in the recent years with the aim of treating the inflammatory component of the disease and hoping to...